Companion Dog Lymphoma Welfare Management

Canine lymphoma is a common and serious cancer - treatment decisions balance welfare against time and cost considerations.

Key Facts

Lymphoma is among the most common cancers in dogs representing around 7-24% of all canine tumours
The CHOP chemotherapy protocol achieves remission in around 80-90% of dogs with multicentric lymphoma
Median survival with CHOP is approximately 12-14 months but some dogs live significantly longer
Prednisone alone can palliate symptoms for weeks to months when chemotherapy is declined
Dogs generally tolerate chemotherapy better than humans with fewer severe side effects
Quality of life during treatment is generally good in dogs achieving and maintaining remission

Welfare Considerations

Canine lymphoma management requires honest conversations about treatment intensity, response probability, and quality of life throughout the disease trajectory. Dogs that achieve remission on CHOP protocols generally maintain excellent quality of life during treatment. When remission ends, quality of life deteriorates rapidly and timely euthanasia decisions are essential.

What You Can Do

Seek oncologist referral promptly if your vet suspects lymphoma
Discuss your expectations and priorities honestly with the oncologist before starting treatment
Monitor quality of life actively throughout chemotherapy using a validated scale
Ask about palliative care options if full chemotherapy is not feasible
Support Morris Animal Foundation canine cancer research programmes